North America Point-of-Care Diagnostics Market - 2025-2033
North America Point-of-Care Diagnostics Market reached US$6.74 billion in 2024 and is expected to reach US$13.25 billion by 2033, growing with a CAGR of 7.90% during the forecast period 2026-2033.
The North America Point-of-Care Diagnostics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A North America Point-of-Care Diagnostics Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Product
Both primary and secondary data sources have been used in the global North America Point-of-Care Diagnostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The North America Point-of-Care Diagnostics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A North America Point-of-Care Diagnostics Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Product
- Infectious Disease Testing Products*
- Blood Glucose Products
- Blood Gas & Electrolyte Products
- Hematology Testing Products
- Urinalysis Products
- Pregnancy and Fertility Testing Products
- Tumor/Cancer Profiling Products
- Drug-of-Abuse Products
- Others
- Lateral Flow Assays*
- Immunoassays
- Molecular Diagnostics
- Microfluidics
- Others
- Infectious Diseases*
- Hematology
- Cardiology
- Endocrinology
- Oncology
- Drug Testing
- Neurology
- Others
- Hospitals & Clinics*
- Diagnostic Laboratories
- Ambulatory Surgery Centers (ASCs)
- Home Care Settings
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global North America Point-of-Care Diagnostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
4. SNIPPET BY PRODUCT
4.1. Snippet by Technology
4.2. Snippet by Application
4.3. Snippet by End-User
5. DYNAMICS
5.1. Impacting Factors
5.1.1. Drivers
5.1.1.1. Rising Advancements in Point-of-Care Diagnostics
5.1.1.2. Rising Aging Population and Chronic Diseases in North America
5.1.1.3. XX
5.1.2. Restraints
5.1.2.1. Connectivity & Data Integration Issues
5.1.2.2. Competition from Alternative Diagnostic Technologies
5.1.2.3. XX
5.1.3. Opportunity
5.1.3.1. Expansion of Home-Based Testing
5.1.3.2. Advancements in Digital and Mobile Health Integration
5.1.4. Impact Analysis
6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
6.1. Market Leaders and Pioneers
6.1.1. Emerging Pioneers and Prominent Players
6.1.2. Established Leaders with the Largest Marketing Brand
6.1.3. Market Leaders with Established Products
6.2. Latest Developments and Breakthroughs
6.3. North America Regulatory and Reimbursement Landscape
6.4. Porter’s Five Forces Analysis
6.5. Supply Chain Analysis
6.6. Patent Analysis
6.7. SWOT Analysis
6.8. Unmet Needs and Gaps
6.9. Recommended Strategies for Market Entry and Expansion
6.10. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
6.11. Pricing Analysis and Price Dynamics
7. POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Infectious Disease Testing Products*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Blood Glucose Products
7.4. Blood Gas & Electrolyte Products
7.5. Hematology Testing Products
7.6. Urinalysis Products
7.7. Pregnancy and Fertility Testing Products
7.8. Tumor/Cancer Profiling Products
7.9. Drug-of-Abuse Products
7.10. Others
8. POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.1.2. Market Attractiveness Index, By Technology
8.2. Lateral Flow Assays*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Immunoassays
8.4. Molecular Diagnostics
8.5. Microfluidics
8.6. Others
9. POINT-OF-CARE DIAGNOSTICS MARKET, BY APPLICATION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Infectious Diseases*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Hematology
9.4. Cardiology
9.5. Endocrinology
9.6. Oncology
9.7. Drug Testing
9.8. Neurology
9.9. Others
10. POINT-OF-CARE DIAGNOSTICS MARKET, BY END-USER
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals & Clinics*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diagnostic Laboratories
10.4. Ambulatory Surgery Centers (ASCs)
10.5. Home Care Settings
11. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
12. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS
12.1. Market Share Analysis and Positioning Matrix
12.2. Strategic Partnerships, Mergers & Acquisitions
12.3. Key Developments in Product Portfolios and Innovations
12.4. Company Benchmarking
13. COMPANY PROFILES
13.1. BD*
13.1.1. Company Overview
13.1.2. Product Portfolio
13.1.2.1. Product Description
13.1.2.2. Product Key Performance Indicators (KPIs)
13.1.2.3. Historic and Forecasted Product Sales
13.1.2.4. Product Sales Volume
14. FINANCIAL OVERVIEW
14.1. Company Revenue
14.1.1. Geographical Revenue Shares
14.1.1.1. Revenue Forecasts
14.1.2. Key Developments
14.1.2.1. Mergers & Acquisitions
14.1.2.2. Key Product Development Activities
14.1.2.3. Regulatory Approvals, etc.
14.1.3. SWOT Analysis
14.2. QuidelOrtho Corporation
14.3. QIAGEN
14.4. Trinity Biotech plc.
14.5. BioM?rieux SA
14.6. F. Hoffmann-La Roche Ltd
14.7. Siemens Healthineers AG
14.8. Abbott
14.9. Danaher Corporation
14.10. Nova Biomedical(LIST NOT EXHAUSTIVE)
15. ASSUMPTIONS AND RESEARCH METHODOLOGY
15.1. Data Collection Methods
15.2. Data Triangulation
15.3. Forecasting Techniques
15.4. Data Verification and Validation
16. APPENDIX
16.1. About Us and Services
16.2. Contact Us
Suggestions for Related Report
• Global Point-of-Care Diagnostics Market (https://www.datamintelligence.com/research-report/point-of-care-diagnostics-market)
• Japan Point-of-care Diagnostics Market (https://www.datamintelligence.com/research-report/japan-point-of-care-diagnostics-market)
• India Point-of-Care Arterial Blood Gas Monitoring Devices Market (https://www.datamintelligence.com/research-report/india-point-of-care-arterial-blood-gas-monitoring-devices-market)
For more medical devices-related reports, please click here (https://www.datamintelligence.com/industry-verticals/medical-devices)
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
4. SNIPPET BY PRODUCT
4.1. Snippet by Technology
4.2. Snippet by Application
4.3. Snippet by End-User
5. DYNAMICS
5.1. Impacting Factors
5.1.1. Drivers
5.1.1.1. Rising Advancements in Point-of-Care Diagnostics
5.1.1.2. Rising Aging Population and Chronic Diseases in North America
5.1.1.3. XX
5.1.2. Restraints
5.1.2.1. Connectivity & Data Integration Issues
5.1.2.2. Competition from Alternative Diagnostic Technologies
5.1.2.3. XX
5.1.3. Opportunity
5.1.3.1. Expansion of Home-Based Testing
5.1.3.2. Advancements in Digital and Mobile Health Integration
5.1.4. Impact Analysis
6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
6.1. Market Leaders and Pioneers
6.1.1. Emerging Pioneers and Prominent Players
6.1.2. Established Leaders with the Largest Marketing Brand
6.1.3. Market Leaders with Established Products
6.2. Latest Developments and Breakthroughs
6.3. North America Regulatory and Reimbursement Landscape
6.4. Porter’s Five Forces Analysis
6.5. Supply Chain Analysis
6.6. Patent Analysis
6.7. SWOT Analysis
6.8. Unmet Needs and Gaps
6.9. Recommended Strategies for Market Entry and Expansion
6.10. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
6.11. Pricing Analysis and Price Dynamics
7. POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Infectious Disease Testing Products*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Blood Glucose Products
7.4. Blood Gas & Electrolyte Products
7.5. Hematology Testing Products
7.6. Urinalysis Products
7.7. Pregnancy and Fertility Testing Products
7.8. Tumor/Cancer Profiling Products
7.9. Drug-of-Abuse Products
7.10. Others
8. POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.1.2. Market Attractiveness Index, By Technology
8.2. Lateral Flow Assays*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Immunoassays
8.4. Molecular Diagnostics
8.5. Microfluidics
8.6. Others
9. POINT-OF-CARE DIAGNOSTICS MARKET, BY APPLICATION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Infectious Diseases*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Hematology
9.4. Cardiology
9.5. Endocrinology
9.6. Oncology
9.7. Drug Testing
9.8. Neurology
9.9. Others
10. POINT-OF-CARE DIAGNOSTICS MARKET, BY END-USER
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals & Clinics*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diagnostic Laboratories
10.4. Ambulatory Surgery Centers (ASCs)
10.5. Home Care Settings
11. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
12. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS
12.1. Market Share Analysis and Positioning Matrix
12.2. Strategic Partnerships, Mergers & Acquisitions
12.3. Key Developments in Product Portfolios and Innovations
12.4. Company Benchmarking
13. COMPANY PROFILES
13.1. BD*
13.1.1. Company Overview
13.1.2. Product Portfolio
13.1.2.1. Product Description
13.1.2.2. Product Key Performance Indicators (KPIs)
13.1.2.3. Historic and Forecasted Product Sales
13.1.2.4. Product Sales Volume
14. FINANCIAL OVERVIEW
14.1. Company Revenue
14.1.1. Geographical Revenue Shares
14.1.1.1. Revenue Forecasts
14.1.2. Key Developments
14.1.2.1. Mergers & Acquisitions
14.1.2.2. Key Product Development Activities
14.1.2.3. Regulatory Approvals, etc.
14.1.3. SWOT Analysis
14.2. QuidelOrtho Corporation
14.3. QIAGEN
14.4. Trinity Biotech plc.
14.5. BioM?rieux SA
14.6. F. Hoffmann-La Roche Ltd
14.7. Siemens Healthineers AG
14.8. Abbott
14.9. Danaher Corporation
14.10. Nova Biomedical(LIST NOT EXHAUSTIVE)
15. ASSUMPTIONS AND RESEARCH METHODOLOGY
15.1. Data Collection Methods
15.2. Data Triangulation
15.3. Forecasting Techniques
15.4. Data Verification and Validation
16. APPENDIX
16.1. About Us and Services
16.2. Contact Us
Suggestions for Related Report
• Global Point-of-Care Diagnostics Market (https://www.datamintelligence.com/research-report/point-of-care-diagnostics-market)
• Japan Point-of-care Diagnostics Market (https://www.datamintelligence.com/research-report/japan-point-of-care-diagnostics-market)
• India Point-of-Care Arterial Blood Gas Monitoring Devices Market (https://www.datamintelligence.com/research-report/india-point-of-care-arterial-blood-gas-monitoring-devices-market)
For more medical devices-related reports, please click here (https://www.datamintelligence.com/industry-verticals/medical-devices)
